Trichomonas vaginalis is an anaerobic parasite that causes trichomoniasis.
This report contains market size and forecasts of Trichomonas Vaginalis Nucleic Acid Test Kit in global, including the following market information:
Global Trichomonas Vaginalis Nucleic Acid Test Kit Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Trichomonas Vaginalis Nucleic Acid Test Kit Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Trichomonas Vaginalis Nucleic Acid Test Kit companies in 2021 (%)
The global Trichomonas Vaginalis Nucleic Acid Test Kit market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Dry PCR Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Trichomonas Vaginalis Nucleic Acid Test Kit include GeneoDx(Sinopharm Industrial Investment Co., Ltd.), Jiangsu Bioperfectus Technologies Co., Ltd., Cepheid(Danaher Corporation), Becton, Dickinson and Company, Hologic, Inc., Quidel Corporation, EUROIMMUN AG, AB Analitica and OSANG Healthcare, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Trichomonas Vaginalis Nucleic Acid Test Kit manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Trichomonas Vaginalis Nucleic Acid Test Kit Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Trichomonas Vaginalis Nucleic Acid Test Kit Market Segment Percentages, by Type, 2021 (%)
Dry PCR
Fluorescence PCR
Global Trichomonas Vaginalis Nucleic Acid Test Kit Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Trichomonas Vaginalis Nucleic Acid Test Kit Market Segment Percentages, by Application, 2021 (%)
Hospital
Clinic
Global Trichomonas Vaginalis Nucleic Acid Test Kit Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Trichomonas Vaginalis Nucleic Acid Test Kit Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Trichomonas Vaginalis Nucleic Acid Test Kit revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Trichomonas Vaginalis Nucleic Acid Test Kit revenues share in global market, 2021 (%)
Key companies Trichomonas Vaginalis Nucleic Acid Test Kit sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Trichomonas Vaginalis Nucleic Acid Test Kit sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
GeneoDx(Sinopharm Industrial Investment Co., Ltd.)
Jiangsu Bioperfectus Technologies Co., Ltd.
Cepheid(Danaher Corporation)
Becton, Dickinson and Company
Hologic, Inc.
Quidel Corporation
EUROIMMUN AG
AB Analitica
OSANG Healthcare
Biomed Diagnostics, Inc.
OPERON, S.A.